Hormone Replacement Therapy Market Size By Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Administration (Oral, Parenteral, Transdermal), By Disease (Menopause, Hypothyroidism, Male Hypothyroidism, Growth Hormone Deficiency, Cancer) Forecast 2021 to 2027

  • Report ID: BMRC 1402 | Number of pages: 200 | Published Date: Jan 2021

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Hormone Replacement Therapy Market Size By Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Administration (Oral, Parenteral, Transdermal), By Disease (Menopause, Hypothyroidism, Male Hypothyroidism, Growth Hormone Deficiency, Cancer) Forecast 2021 to 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Hormone Replacement Therapy Market is valued at USD 21.04 Billion in 2020 and expected to reach USD 36.54 Billion by 2027 with the CAGR of 8.20% over the forecast period.

Global Hormone Replacement Therapy Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027The growing awareness on post-menopausal issues among women is one of the major factors driving the growth of Global Hormone Replacement Therapy Market.

Scope of Global Hormone Replacement Therapy Market Report-

Hormone replacement therapy is a treatment used to release symptoms of the menopause. The main advantage is that it is a very effective method of controlling menopausal symptoms, and it can make an important difference to a woman’s quality of life and security. Hormone replacement therapy can also reduce a woman’s risk of developing osteoporosis and cancer of the colon and rectum. Additionally, hormones are secreted predominantly from the endocrine glands and absorbed into the bloodstream. The hormones that have been most commonly utilised in hormone replacement therapy are progesterone, estrogen, testosterone, adrenal hormones, DHEA, thyroid hormones, pregnenolone, melatonin, and human growth hormone. It is the most effective treatment for menopause symptoms. Systemic hormone replacement therapy helps in treating cancer, rheumatoid arthritis and other diseases. Moreover, this treatment is particularly favorable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. It may also protect against osteoporosis.

Global Hormone Replacement Therapy market report is segmented on the basis of product, administration, disease and region & country level. Based upon product, global hormone replacement therapy market is classified into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy and testosterone replacement therapy. Based upon administration, the market is divided into oral, parenteral and transdermal. Based upon disease, global hormone replacement therapy market is classified into menopause, hypothyroidism, male hypothyroidism, growth hormone deficiency, cancer and other.

The regions covered in this Hormone Replacement Therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Hormone Replacement Therapy sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Afria, etc.

Key Players for Hormone Replacement Therapy–

Global Hormone Replacement Therapy report covers prominent player’s Abbott Laboratories, Novo Nordisk, Novartis, Merck Serono, Bayer Healthcare, Eli Lilly, Mylan Laboratories, Roche, Genentech, Orion Pharma AB, Allergen Plc and others.

Hormone Replacement Therapy

News-

Big Study Found No Rise in Death Risk among Women who Took Hormone Therapy

September 12th, 2017; after a massive study of hormone replacement therapy was halted due to higher rates of breast cancer, heart attack and stroke among women assigned to the drugs to treat menopausal symptoms, a new follow-up study has found those women had no higher risk of death as of 2014 than participants who took a placebo.

The Growing Awareness about Hormone Replacement is the Key Factor Influencing the Global Hormone Replacement Therapy Market Growth.

Increasing healthcare expenditure due to growing awareness about health related problems. For example, According to OECD, the US spent $10,209 on healthcare per capita, or per person, in 2017. That's more than any other country in OECD's 36-country consortium, and over $2,000 more than Switzerland, the second-highest spending country. In addition, rising drug development and hormonal imbalance disorders with rising geriatric population are also boosting the hormone replacement therapy market growth. Additionally, the rising women’s population between the age group of 45 to 60, which increases the range of menopausal window due to this factor the demand of hormonal replacement therapy, is also growing. However, the hormone replacement therapy has number of side effects which may hamper the market growth. For example, fluid retention, indigestion, headache, and depression, bloating, swelling, nausea, leg cramps. Combined hormone replacement therapy slightly increases the risk of developing breast cancer, womb cancer, ovarian cancer and stroke. For example, Women who take hormone replacement therapy for more than 1 year have a higher risk of breast cancer than women who never use hormone replacement therapy. The risk is linked to all types of hormone replacement therapy except vaginal oestrogen. In spite of that, technological advancements in this field may create the number of opportunities within the forecast period.

North America is expected to Dominate the Global Hormone Replacement Therapy Market

North America is expected to dominate the global hormone replacement therapy market due to the increasing awareness about the hormonal replacement therapy And Increasing number of women’s which have menopause problems in this region.  For example, National Center for Biotechnology Information, in the United States, approximately 1.3 million women become menopausal each year and, 1% of women experience premature menopause before the age of 40. The Asia Pacific is expected to experience surge of demand too, owing to the factors such as increased awareness levels among the end users and improving healthcare infrastructure. Rising geriatric population is one of the primary factors responsible for the growth of the hormonal replacement therapy market in the Europe.

 

Hormone Replacement Therapy Market Report Coverage

Report Analysis Details
Years : 2019 Market Size in 2019: US$ 19.45 Billion 
Market Historical Analysis: 2015-2019 Forecast Analysis: 2020-2026 
Forecast Period CAGR %: 8.2% Market Size Expected to reach in 2026: US$ 33.77 Billion 
Pages: 200 Tables, Charts & Figures: 179
Top Companies: Abbott Laboratories, Novo Nordisk, Novartis, Merck Serono, Bayer Healthcare, Eli Lilly, Mylan Laboratories, Roche, Genentech, Orion Pharma AB, Allergen Plc
Market Segmentation: Product, Disease, Administration
Regional Analysis:  North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

Key Benefits for Global Hormone Replacement Therapy Market Report-

  • Global hormone replacement therapy market report covers in depth historical and forecast analysis.
  • Global hormone replacement therapy market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global hormone replacement therapy market report helps to identify opportunities in market place.
  • Global hormone replacement therapy market report covers extensive analysis of emerging trends and competitive landscape.

Global Hormone Replacement Therapy Market Segmentation:–

By Product:

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy

By Administration:

  • Oral
  • Parenteral
  • Transdermal

By Disease:

  • Menopause
  • Hypothyroidism
  • Male Hypothyroidism
  • Growth Hormone Deficiency
  • Cancer
  • Others

By Regional & Country Analysis:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa


Frequently Asked Questions (FAQ) :
Increasing healthcare expenditure due to growing awareness about health related problems. For example, According to OECD, the US spent $10,209 on healthcare per capita, or per person, in 2017. That's more than any other country in OECD's 36-country consortium, and over $2,000 more than Switzerland, the second-highest spending country.
Hormone Replacement Therapy Market is valued at USD 21.04 Billion in 2020 and expected to reach USD 36.54 Billion by 2027 with the CAGR of 8.20% over the forecast period. Detail Information
Hormone Replacement Therapy report covers prominent player’s Abbott Laboratories, Novo Nordisk, Novartis, Merck Serono, Bayer Healthcare, Eli Lilly, Mylan Laboratories, Roche, Genentech, Orion Pharma AB, Allergen Plc
North America is expected to dominate the global hormone replacement therapy market due to the increasing awareness about the hormonal replacement therapy And Increasing number of women’s which have menopause problems in this region.



Interested in this report?

Hormone Replacement Therapy Market Size Segmentation and Foresight to 2027

report cover

Request for Table of Content

Hormone Replacement Therapy Market Size By Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Administration (Oral, Parenteral, Transdermal), By Disease (Menopause, Hypothyroidism, Male Hypothyroidism, Growth Hormone Deficiency, Cancer) Forecast 2021 to 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?